Fundamental analysis by سیگنال پلاس about Stock دارو on 7/21/2025

#Medicine The drug made 1.5 times the last spring The spring report shows that the company has managed to increase gross profit by 5 % with a 5 percent increase over the same period last year. The company, which had announced 2 billion tomans last spring, has increased this number to 2 billion tomans this year. The total net profit was 2 billion tomans. @navasan_vip_plus